Table of Contents

    Topic review

    NOG Gene

    Subjects: Genetics
    View times: 3
    Submitted by: Lily Guo
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    noggin

    1. Introduction

    The NOG gene provides instructions for making a protein called noggin. This protein is involved in the development of many body tissues, including nerve tissue, muscles, and bones. Noggin's role in bone development makes it important for proper joint formation.

    Noggin interacts with members of a group of proteins called bone morphogenetic proteins (BMPs). These proteins help control the development of bone and other tissues. In order to begin these developmental processes, BMPs attach (bind) to other proteins called receptors, and this binding stimulates specific cellular processes. The noggin protein regulates the activity of certain BMPs by attaching to them and blocking them from binding to the receptor, which leads to a decrease in BMP signaling.

    2. Health Conditions Related to Genetic Changes

    2.1. Tarsal-carpal coalition syndrome

    Several mutations in the NOG gene have been identified in people with a condition called tarsal-carpal coalition syndrome. This condition is characterized by fusion of the individual bones in the wrists (the carpal bones) and in the ankles (the tarsal bones) as well as fusion at the joints between the bones that make up each finger and toe (symphalangism). Symphalangism makes the fingers and toes stiff and difficult to bend.

    This condition is caused by mutations in the NOG gene that change single protein building blocks (amino acids) in the noggin protein. These mutations alter the structure or stability of noggin, impair the transport of noggin out of the cell, or reduce the protein's ability to bind to BMPs, resulting in a reduction of functional noggin protein. With decreased noggin function, BMPs abnormally stimulate bone formation in joint areas, where there should be no bone, causing the bone fusions seen in people with tarsal-carpal coalition syndrome.

    2.2. Other disorders

    Several other bone-related disorders are caused by mutations in the NOG gene. These gene mutations change single protein building blocks (amino acids) in the noggin protein.

    Proximal symphalangism is characterized by fusion at the joints between the bones in the fingers and toes, particularly at the joint at the base of the digit. Other signs and symptoms include abnormally short middle fingers, webbed toes, and hearing loss that is due to fusion of the bones in the ears (stapes fixation).

    Multiple synostoses syndrome 1 is characterized by symphalangism and characteristic facial features, such as a broad nose and thin lips. In addition, affected individuals can have fusion of the bones in the hands, feet, hips, and upper part of the spine (cervical vertebrae). People with this condition can have hearing loss due to stapes fixation.

    People with stapes ankylosis with broad thumb and toes (also known as Teunissen-Cremers syndrome) have hearing loss due to stapes fixation, farsightedness, and broad thumbs and big toes. Some affected individuals may have fusion of the cervical vertebrae and characteristic facial features like those seen in multiple synostoses syndrome 1.

    Brachydactyly type B2 is characterized by short fingers and toes, which occurs because the middle bone of the digit or the bone that forms the tip of the digit is abnormally small or absent. In addition, people with this condition can have symphalangism, fusion of the carpal bones, and connection of the skin between two or more fingers or toes (syndactyly).

    As in tarsal-carpal coalition syndrome, the NOG gene mutations that cause these conditions reduce the amount of functional noggin protein. For reasons that are unknown, the same mutations can cause different disorders in different people. Because of a shared genetic cause and overlapping features, researchers have suggested that these conditions, including tarsal-carpal coalition syndrome, represent a spectrum of related conditions referred to as NOG-related-symphalangism spectrum disorder (NOG-SSD).

    3. Other Names for This Gene

    • NOGG_HUMAN
    • noggin precursor
    • SYM1
    • symphalangism 1 (proximal)
    • SYNS1

    The entry is from https://medlineplus.gov/genetics/gene/nog

    References

    1. Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE,Milunsky JM, Lesperance MM. Autosomal dominant stapes ankylosis with broad thumbsand toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsenseand frameshift mutations in NOG, the gene encoding noggin. Am J Hum Genet. 2002Sep;71(3):618-24.
    2. Dixon ME, Armstrong P, Stevens DB, Bamshad M. Identical mutations in NOG cancause either tarsal/carpal coalition syndrome or proximal symphalangism. GenetMed. 2001 Sep-Oct;3(5):349-53.
    3. Drawbert JP, Stevens DB, Cadle RG, Hall BD. Tarsal and carpal coalition andsymphalangism of the Fuhrmann type. Report of a family. J Bone Joint Surg Am.1985 Jul;67(6):884-9.
    4. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L,Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoin DL, Cohn DH, Goodman FR,Reardon W, Patton M, Francomano CA, Warman ML. Heterozygous mutations in the geneencoding noggin affect human joint morphogenesis. Nat Genet. 1999Mar;21(3):302-4.
    5. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S. Structural basis of BMPsignalling inhibition by the cystine knot protein Noggin. Nature. 2002 Dec12;420(6916):636-42.
    6. Hogan BL. Bone morphogenetic proteins: multifunctional regulators ofvertebrate development. Genes Dev. 1996 Jul 1;10(13):1580-94. Review.
    7. Krause C, Guzman A, Knaus P. Noggin. Int J Biochem Cell Biol. 2011Apr;43(4):478-81. doi: 10.1016/j.biocel.2011.01.007.
    8. Lehmann K, Seemann P, Silan F, Goecke TO, Irgang S, Kjaer KW, Kjaergaard S,Mahoney MJ, Morlot S, Reissner C, Kerr B, Wilkie AO, Mundlos S. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet. 2007 Aug;81(2):388-96.
    9. Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN,Eimon PM, Harland RM, Warman ML. Human disease-causing NOG missense mutations:effects on noggin secretion, dimer formation, and bone morphogenetic proteinbinding. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11353-8.
    10. Potti TA, Petty EM, Lesperance MM. A comprehensive review of reportedheritable noggin-associated syndromes and proposed clinical utility of onebroadly inclusive diagnostic term: NOG-related-symphalangism spectrum disorder(NOG-SSD). Hum Mutat. 2011 Aug;32(8):877-86. doi: 10.1002/humu.21515.
    11. Usami S, Abe S, Nishio S, Sakurai Y, Kojima H, Tono T, Suzuki N. Mutations in the NOG gene are commonly found in congenital stapes ankylosis withsymphalangism, but not in otosclerosis. Clin Genet. 2012 Dec;82(6):514-20. doi:10.1111/j.1399-0004.2011.01831.x.
    More

    Keywords